Abstract:We aimed at assessing anxiety‐ and depressive‐like behaviors in Wistar‐Kyoto (WKY) rats and determining whether these were associated to changes in levels of neuroinflammatory markers (Iba‐1, CD86, Ym1, GFAP, S100A10) and mediators (interleukins IL‐1β, IL‐6, TNF‐α) in the prefrontal cortex (PFC), hippocampus, and amygdala. We found that WKY rats displayed increased anxiety‐like behaviors, but inconsistent depressive‐like behaviors, and severely diminished locomotor activity. Additionally, we found no neuroinflammatory changes in any of the assessed regions. Our data question some aspects of the validity of the WKY model of major depressive disorder (MDD) and highlight the necessity of carefully interpreting data considering the evidenced locomotor alterations. Reductionistic research on depressive disorders has been hampered by the limitations of animal models. Recently, it has been hypothesized that neuroinflammation is a key player in depressive disorders. The Wistar‐Kyoto (WKY) rat is an often‐used animal model of depression, but no information so far exists on its neuroinflammatory profile. As such, we compared male young adult WKY rats to Wistar (WS) controls, with regard to both behavioral performance and brain levels of key neuroinflammatory markers. We first assessed anxiety‐ and depression‐like behaviors in a battery consisting of the Elevated Plus Maze (EPM), the Novelty Suppressed Feeding (NSFT), Open Field (OFT), Social Interaction (SIT), Forced Swim (FST), Sucrose Preference (SPT), and Splash tests (ST). We found that WKY rats displayed increased NSFT feeding latency, decreased OFT center zone permanence, decreased EPM open arm permanence, decreased SIT interaction time, and increased immobility in the FST. However, WKY rats also evidenced marked hypolocomotion, which is likely to confound performance in such tests. Interestingly, WKY rats performed similarly, or even above, to WS levels in the SPT and ST, in which altered locomotion is not a significant confound. In a separate cohort, we assessed prefrontal cortex (PFC), hippocampus and amygdala levels of markers of astrocytic (GFAP, S100A10) and microglial (Iba1, CD86, Ym1) activation status, as well as of three key proinflammatory cytokines (IL‐1β, IL‐6, TNF‐α). There were no significant differences between strains in any of these markers, in any of the regions assessed. Overall, results highlight that behavioral data obtained with WKY rats as a model of depression must be carefully interpreted, considering the marked locomotor activity deficits displayed. Furthermore, our data suggest that, despite WKY rats replicating many depression‐associated neurobiological alterations, as shown by others, this is not the case for neuroinflammation‐related alterations, thus representing a novel limitation of this model.

Unmoving and uninflamed: Characterizing neuroinflammatory dysfunction in the Wistar‐Kyoto rat model of depression

Circuit-wide proteomics profiling reveals brain region-specific protein signatures in the male WKY rats with endogenous depression

Validation of Wistar-Kyoto rats kept in solitary housing as an animal model for depression using voxel-based morphometry

Characterization of pain-, anxiety-, and cognition-related behaviors in the complete Freund's adjuvant model of chronic inflammatory pain in Wistar–Kyoto rats

Chronic mild stress-induced dysregulation of MAPK and PI3K/AKT signaling in the hippocampus and medial prefrontal cortex of WKY female rats

Partial resistance to citalopram in a Wistar–Kyoto rat model of depression: An evaluation using resting-state functional MRI and graph analysis

Comparison of Chronic Restraint Stress- and Lipopolysaccharide-Induced Mouse Models of Depression: Behavior, C-Fos Expression, and Microglial and Astrocytic Activation

Systematic analysis of severity in a widely used cognitive depression model for mice

Neuroinflammation-Induced Parvalbumin Interneuron and Oscillation Deficits Might Contribute to Neurobehavioral Abnormities in a Two-Hit Model of Depression

Anhedonic behaviour in a TLR7-driven neuroinflammation mouse model is associated with impaired thalamostriatal signalling and immune cell ingress into the brain

Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders

A novel two-hit insomnia and inflammation rodent model of depressive-like behaviors

Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression.

Regional alterations of cerebral [18F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats

Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation

Impairments of Behavior, Information Flow Between Thalamus and Cortex, and Prefrontal Cortical Synaptic Plasticity in an Animal Model of Depression

Tryptophan-kynurenine metabolic characterization in the gut and brain of depressive-like rats induced by chronic restraint stress

A new experimental design to study inflammation-related versus non-inflammation-related depression in mice

Neuroinflammatory transcriptional signatures in the entorhinal cortex based on lipopolysaccharide-induced depression model in mice

Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites

Astrocyte-specific inhibition of sigma-1 receptor leads to depressive-like behaviors in mice via activation of NF-κB-induced neuroinflammation